ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 766

Neutrophil Extracellular Traps Are a Source of Extracellular High Mobility Group Box-1: Association with Clinical and Histopathological Features in Patients with Lupus Nephritis

Laura Patricia Whittall1, Diana Gómez-Martín1, Jiram Torres-Ruíz2, Alejandro Zentella Dehesa1, Miguel Tapia-Rodríguez1 and Jorge Alcocer-Varela1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Activity score, Lupus, lupus nephritis and neutrophils, NETosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Current evidence suggests that neutrophils play an important role in the pathophysiology of lupus nephritis (LN) mainly through the secretion of type I IFN and the production of Neutrophil Extracellular Traps (NETs). This type of cell death releases proinflammatory molecules, including High Mobility Group Box-1 (HMGB1). HMGB1 acts as an alarmin once released into the extracellular space and induces the synthesis of proinflammatory cytokines through its interaction with diverse receptors. Elevated levels of this protein have been associated with global disease activity as well as LN. However, the precise source of extracellular HMGB1 has not been addressed. The aim of this study was to analyze the expression of HMGB1 in NETs of patients with LN and its association with clinical and histopathological characteristics of the disease.

Methods:

Twenty-three patients with LN confirmed by biopsy as well as 14 SLE patients with active disease (SLEDAI ≥ 6) and no evidence of LN were included. Clinical and laboratory features where obtained. NETs and the expression of HMGB1 were assessed by immunofluorescence and confocal microscopy. Besides, serum HMGB1 levels were measured by ELISA.

Results:

81% of the patients were women and the mean age was 30.6 years. Patients with LN were characterized by a higher expression of HMGB1 in NETs compared to patients without LN (Spontaneous: 57 vs 30.4, p=0.027; LPS: 55.8 vs 24.9, p=0.005), even though, we did not find differences in serum HMGB1 levels (p=0.920) nor the amount of NETs (Spontaneous:p=0.230, LPS p=0.263). Nonetheless, we found a positive correlation between serum HMGB1 and HMGB1 expression in LPS-induced NETs (r=0.447, p=0.017). The expression of HMGB1 in spontaneous NETs correlated with serum creatinine (r=0.481, p=0.003), proteinuria/creatinuria index (r=0.34, p=0 .039), % of glomerular filtration rate descent (r=0.543, p=0.001), SLEDAI score (r=0.508, p=0.001), anti-DNAds (r=0.514, p=0.001) and diverse histopathological findings of active LN in the renal biopsy as shown in Table 1.

Conclusion:

Our findings support the hypothesis that NETs are a relevant source of extracellular HMGB1 in patients with LN. The positive correlation between HMGB1 from spontaneous NETs and histopathologic findings of active proliferative LN suggest the role of this alarmin in the pathophysiology of renal damage in SLE.

Table 1: Correlations between the mean fluorescence intensity of HMGB1 in spontaneous NETs and histopathological findings in renal biopsies.

Feature

Rho

p value

Activity Index

0.581

0.001

% of fibrinoid necrosis

0.621

0.002

% of cellular crescents

0.641

0.001

% of leukostasis

0.452

0.030

% of endocapilar proliferation

0.455

0.029

% of wire loop lesions

0.420

0.046


Disclosure: L. P. Whittall, None; D. Gómez-Martín, None; J. Torres-Ruíz, None; A. Zentella Dehesa, None; M. Tapia-Rodríguez, None; J. Alcocer-Varela, None.

To cite this abstract in AMA style:

Whittall LP, Gómez-Martín D, Torres-Ruíz J, Zentella Dehesa A, Tapia-Rodríguez M, Alcocer-Varela J. Neutrophil Extracellular Traps Are a Source of Extracellular High Mobility Group Box-1: Association with Clinical and Histopathological Features in Patients with Lupus Nephritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/neutrophil-extracellular-traps-are-a-source-of-extracellular-high-mobility-group-box-1-association-with-clinical-and-histopathological-features-in-patients-with-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophil-extracellular-traps-are-a-source-of-extracellular-high-mobility-group-box-1-association-with-clinical-and-histopathological-features-in-patients-with-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology